Register

Browse Companies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9
Top 10 Penny Stocks
Symbol: Price: Chg %: Volume:
MHYS 0.0002 100 498657582
DNNC 0.0002 0 150634997
DRGV 0.0002 0 131762882
OCFN 0.0002 0 127544361
QASP 0.0002 0 111980250
PPJE 0.0002 -33.33 54318152
UNGS 0.0002 0 46942298
TXHE 0.0002 100 43028998
TCPS 0.0002 0 43017507
MSPC 0.0002 -66.67 41400967
FOGC 0.0002 0 28214668
INOH 0.0002 0 24310000
PLKD 0.0002 0 16170000
NSEH 0.0002 0 15942599
TADF 0.0002 0 12042000
YTRV 0.0002 0 11849998
ICNM 0.0002 -0 11293620
MPIX 0.0002 0 8001181
KABX 0.0002 0 7510000
EKWX 0.0002 0 6360000
SKTO 0.0002 0 5678563
HDSI 0.0002 -0 5432800
HDSI 0.0002 -0 5432800
NHPI 0.0002 0 4500000
CSLI 0.0002 0 4300000
GERS 0.0002 0 3828129
PFMS 0.0002 0 3760000
MNDP 0.0002 0 3250099
MDIN 0.0002 0 2790138
WWAG 0.0002 0 2750000

0001 Stocks

Sort By: Date Alphabetically

MultiCell Technologies, Inc. (MCET) Loses Momentum After Recent Climb

Thumbnail
MultiCell Technologies, Inc. (MCET) spiked last Monday after a press release came out, announcing the company had been granted a U.S. patent covering novel drug compositions and platform technologies used for fighting virus infection and cancer. MCET climbed by 57% in price on a 750 thousand share volume at a $846,1 thousand trade value. These were the highest numbers for the company in over five months and the first significant increase since late March. The next day, however, the ticker suffered... more

Bergio International, Inc. (BRGO) Files 10-Q To Report No Progress

Thumbnail
On Thursday, Bergio International, Inc. (BRGO) managed to timely submit its 10-Q for the period ended June 30, 2014. The next day, BRGO issued a press release in which it commented on the results from the report. As can be seen in the filing, the financials did not account for much progress made by the company: Cash: $65,1 thousand Total current assets: $2,1 million Total current liabilities: $879,1 thousand Revenues: $361,1 thousand Net loss: $580,1 thousand In the press release from August 15, BRGO... more

Puramed Bioscience, Inc. (PMBS) Back To Triple Zero Bottom

Thumbnail
Puramed Bioscience, Inc. (PMBS) ended last week with a slide down, lowering the price back to the $0.0001 mark. PMBS's efforts have had no success in maintaining a long-lasting interest in the company. The price of PMBS' stock has been low throughout recent events. The announcements about the company's plans for future development have been insufficient to halt the decline. PMBS' downfall began after an 8-K issued on July 11 reported about a number of decisions that shareholders seemingly did not approve... more

mPhase Technologies, Inc. (XDSL) Sinks Further Down

Thumbnail
The efforts mPhase Technologies, Inc. (XDSL) has made to attract investors' interest lately have had no reaction on the market. XDSL recently reported a growth in revenues in the last quarter of its fiscal year ended June 30, 2014. The company stated in a press release issued on August 5 that its revenues have grown by approximately 6% compared to the previous quarter. We can take a look at XDSL's 10-Q for the period ended March 31, 2014 to see what this would translate into: Cash: $87,4 thousand Total... more
First 1 2 3 4 5 6 7 8 9 10 >> Last